Date(s) - 18 Feb 2020 until 18 Feb 2020
8:00 AM - 9:00 AM
Arizona Commerce Authority
Connect with Arizona life science entrepreneurs, innovators, and thought leaders each month at the AZBio PEERS breakfast.
This monthly breakfast meeting is coordinated by executives from across your bioscience community to provide new opportunities for professional education, engagement, and resource sharing.
Join us for the February 2020 gathering of AZBio PEERS:
Date: Tuesday, February 18, 2020
Time: 8:00 AM – 9:00 AM
Location: Arizona Commerce Authority, 100 N 7th Ave, Phoenix, AZ 85007
Cost: Complimentary – Registration Required
8:00 – Registration and Networking
8:30 – Meeting Begins
- Welcome – George Colberg, CEO & co-founder, Kalos Therapeutics
- Professional Education – Intellectual Property
9:00 – Meeting Concludes
Introduction: George Colberg
Speaker: Jason Jardine, Knobbe Martens
Appreciated for his strategic analysis and solutions that fit each client’s specific needs, Jason Jardine represents a diverse clientele in all aspects of intellectual property acquisition, protection and enforcement across the U.S. and abroad. Amiable, easy-going, flexible and smart, Jason is sensitive to his client’s bottom line and seeks to diligently conserve their resources at every turn. Clients appreciate not only that Jason’s practice is truly multi-faceted, but also that he is absolutely committed to achieving their objectives and financial goals.
Jason’s clients include fast-growth and emerging companies seeking to acquire their first patent, which is usually the most difficult to obtain, as well as middle market and major corporations with thousands of IP assets and multiple families of patents. Jason’s clients are international in scope, with special attention to California and Arizona businesses. Jason focuses on helping to acquire patents, including patent prosecution, planning and advice related to infringement. Jason also advises on the acquisition and enforcement of trademarks and copyrights, prepares infringement and invalidity studies, and navigates clients through and beyond licensing and the IP due diligence issues that permeate M&A activity.
Interested in sponsoring this meeting? Contact AZBio